Effect of nicotine on quinpirole-induced checking behavior in rats: Implications for obsessive-compulsive disorder

被引:46
作者
Tizabi, Y
Louis, VA
Taylor, CT
Waxman, D
Culver, KE
Szechtman, H
机构
[1] Howard Univ, Coll Med, Dept Pharmacol, Washington, DC 20059 USA
[2] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada
关键词
nicotine; nicotinic receptors; dopamine; quinpirole; obsessive-compulsive disorder; compulsive checking;
D O I
10.1016/S0006-3223(01)01207-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Rats treated chronically in a large, open field with the dopamine D-2/D-3 receptor agonist quinpirole (QNP) develop compulsive checking behavior as defined by a set of behavioral criteria. This paradigm has been suggested as an animal model of obsessive-compulsive disorder (OCD). Because nicotine blocks various behaviors induced by ontogenetic QNP administration, we asked whether nicotine could attenuate QNP-induced compulsive checking. Methods: Adult mate Long-Evans rats (n = 14/group) were treated twice weekly with saline (control), or with QNP (0.5 mg/kg) for 14-16 injections. On the last two injections, rats were pretreated in random order with an acute dose of nicotine (0.3 mg/kg base) or saline 10 min before administration of QNP or saline; and the effects on checking behavior was examined. The effects of chronic QNP treatment on nicotinic receptors in discrete brain regions were also determined. Results: Chronic QNP resulted in compulsive checking and increases in cerebellar alpha(4)beta(2) and alpha(7) nicotinic receptor densities. Nicotine pretreatment significantly reduced one of the three measures of compulsive checking behavior. Conclusions: Nicotine attenuates some symptoms of compulsive checking in a rat model of OCD; however, the mechanisms of this effect and therapeutic efficacy of nicotinic agonists in OCD require further study. Biol Psychiatry 2002;51:164-171 (C) 2002 Society of Biological Psychiatry.
引用
收藏
页码:164 / 171
页数:8
相关论文
共 61 条
  • [1] Schizophrenia, sensory gating, and nicotinic receptors
    Adler, LE
    Olincy, A
    Waldo, M
    Harris, JG
    Griffith, J
    Stevens, K
    Flach, K
    Nagamoto, H
    Bickford, P
    Leonard, S
    Freedman, R
    [J]. SCHIZOPHRENIA BULLETIN, 1998, 24 (02) : 189 - 202
  • [2] Arneric S. P., 1996, EXPERT OPIN INV DRUG, V5, P79, DOI [10.1517/13543784.5.1.79, DOI 10.1517/13543784.5.1.79]
  • [3] ALPHA-BUNGAROTOXIN BINDING-SITES IN RAT HIPPOCAMPAL AND CORTICAL CULTURES - INITIAL CHARACTERIZATION, COLOCALIZATION WITH ALPHA-7 SUBUNITS AND UP-REGULATION BY CHRONIC NICOTINE TREATMENT
    BARRANTES, GE
    ROGERS, AT
    LINDSTROM, J
    WONNACOTT, S
    [J]. BRAIN RESEARCH, 1995, 672 (1-2) : 228 - 236
  • [4] Low prevalence of smoking among patients with obsessive-compulsive disorder
    Bejerot, S
    Humble, M
    [J]. COMPREHENSIVE PSYCHIATRY, 1999, 40 (04) : 268 - 272
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] Obsessive-compulsive disorder and Tourette’s syndrome
    Randall D. Buzan
    Jay H. Shore
    Christopher O’Brien
    Christopher Schneck
    [J]. Current Treatment Options in Neurology, 2000, 2 (2) : 125 - 139
  • [7] A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats
    Culver, KE
    Rosenfeld, JM
    Szechtman, H
    [J]. PSYCHOPHARMACOLOGY, 2000, 151 (2-3) : 202 - 210
  • [8] Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings
    Dalack, GW
    Healy, DJ
    Meador-Woodruff, JH
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (11) : 1490 - 1501
  • [9] Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics
    Decker, MW
    Meyer, MD
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (06) : 917 - 923
  • [10] Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder
    Delgado, PL
    Moreno, FA
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 : 21 - 25